Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient‐level pooled analysis-Reference-Cited by-同舟云学术

Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient‐level pooled analysis

Published:2012-03 Issue:3 Volume:28 Page:258-267
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Chaudhuri Ajay¹,Rosenstock Julio²,DiGenio Andres³,Meneghini Luigi⁴,Hollander Priscilla⁵,McGill Janet B.⁶,Dandona Paresh¹,Ilgenfritz John⁷,Riddle Matthew⁸

Affiliation:

1. State University of New York at Buffalo and Kaleida Health Buffalo NY USA

2. Dallas Diabetes and Endocrine Center at Medical City Dallas TX USA

3. Sanofi‐aventis US Bridgewater NJ USA

4. University of Miami Miller School of Medicine Miami FL USA

5. Baylor University Medical Center Dallas TX USA

6. Washington University in St. Louis School of Medicine St. Louis MO USA

7. United Biosource Corporation Blue Bell PA USA

8. Oregon Health & Science University Portland OR USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.1305

Reference40 articles.

1. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus

2. Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus

3. Diabetes and Cardiovascular Disease

4. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003-2004

5. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial;Cardiovascular Diabetology;2021-06-22

2. Self-reported medication adherence among patients with diabetes or hypertension, Médecins Sans Frontières Shatila refugee camp, Beirut, Lebanon: A mixed-methods study;PLOS ONE;2021-05-10

3. Pharmacokinetics, Safety and Tolerability of Chiglitazar, A Novel Peroxisome Proliferator-Activated Receptor (PPAR) Pan-Agonist, in Healthy Chinese Volunteers: A Phase I Study;Clinical Drug Investigation;2019-04-29

4. Dyslipidemia in Diabetes;Encyclopedia of Endocrine Diseases;2019

5. The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes;Cardiovascular Diabetology;2017-06-06